mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |